Role of NAT10-mediated ac4C acetylation of ENO1 mRNA in glycolysis and apoptosis in non-small cell lung cancer cells
BMC Pulmonary Medicine · 2025
DOI: 10.1186/s12890-024-03463-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Pulmonary Medicine, 2025. Verfasst von Yanqing Yuan und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Second People's Hospital of Hunan Province(Brain Hospital of Hunan Province), No. 427, Section 3, Furong Middle Road, Changsha, 410000, Hunan Pro…. Hauptthemen laut MEDLINE: Apoptosis, Phosphopyruvate Hydratase, Lung Neoplasms, Tumor Suppressor Proteins. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Regarding mir-145-5p targeting SOX2, it inhibits non-small cell lung cancer proliferation, metastasis, and angiogenesis through the Wnt/β- Catenin signaling pa….
Abstract (Originalsprache)
Abnormal expression of N-acetyltransferase 10 (NAT10) has been shown to promote the progression of various tumors, including non-small cell lung cancer (NSCLC). This study was designed to investigate the role of NAT10 in NSCLC and the underlying mechanism. Reverse transcription-quantitative polymerase chain reaction and Western blot were used to analyze the levels of NAT10 in NSCLC cell lines. The cell viability, proliferation, and apoptosis of A549 and PC9 cell lines were detected by cell counting kit-8, colony formation, and flow cytometry. N4-acetylcytidine (ac 4 C)-RNA immunoprecipitation assay was performed to detect the level of ac 4 C of α-enolase (ENO1) mRNA in A549 and PC9 cell lines. The relationship between NAT10 and ENO1 was performed by dual-luciferase reporter assay. NAT10 was increased in NSCLC cell lines. The ac 4 C level of ENO1 mRNA in A549 and PC9 cell lines was downregulated after NAT10 inhibition. Knockdown of NAT10 inhibited cell viability and glycolysis and promoted cell apoptosis in A549 and PC9 cell lines, and the results were reversed after ENO1 overexpressing. NAT10 regulated glycolysis and apoptosis in NSCLC via ac 4 C acetylating ENO1, which might provide new ideas for the clinical treatment of NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second People's Hospital of Hunan Province(Brain Hospital of Hunan Province), No. 427, Section 3, Furong Middle Road, Changsha, 410000, Hunan Province, China.
- The Second People's Hospital of Hunan Province(Brain Hospital of Hunan Province), No. 427, Section 3, Furong Middle Road, Changsha, 410000, Hunan Province, China. yidaijiao725@126.com.
Förderung
- Regarding mir-145-5p targeting SOX2, it inhibits non-small cell lung cancer proliferation, metastasis, and angiogenesis through the Wnt/β- Catenin signaling pa…
Zitieren
APA
Yuan, Y., Li, N., Zhu, J., Shao, C., Zeng, X., & Yi, D. (2025). Role of NAT10-mediated ac4C acetylation of ENO1 mRNA in glycolysis and apoptosis in non-small cell lung cancer cells. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-024-03463-2
Vancouver
Yuan Y, Li N, Zhu J, Shao C, Zeng X, Yi D. Role of NAT10-mediated ac4C acetylation of ENO1 mRNA in glycolysis and apoptosis in non-small cell lung cancer cells. BMC Pulmonary Medicine. 2025. doi:10.1186/s12890-024-03463-2
BibTeX
@article{Yuan2025,
author = {Yuan, Yanqing and Li, Na and Zhu, Jingui and Shao, Chun and Zeng, Xiangbo and Yi, Daijiao},
title = {Role of NAT10-mediated ac4C acetylation of ENO1 mRNA in glycolysis and apoptosis in non-small cell lung cancer cells},
journal = {BMC Pulmonary Medicine},
year = {2025},
doi = {10.1186/s12890-024-03463-2}
}
EUVIMED